Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS

Author:

Saintas Emily,Abrahams Liam,Ahmad Gulshan T.,Ajakaiye Anu-Oluwa M.,AlHumaidi Abdulaziz S. H. A. M.,Ashmore-Harris Candice,Clark Iain,Dura Usha K.,Fixmer Carine N.,Ike-Morris Chinedu,Mato Prado Mireia,Mccullough Danielle,Mishra Shishir,Schöler Katia M. U.,Timur Husne,Williamson Maxwell D. C.,Alatsatianos Markella,Bahsoun Basma,Blackburn Edith,Hogwood Catherine E.,Lithgow Pamela E.,Rowe Michelle,Yiangou Lyto,Rothweiler Florian,Cinatl Jindrich,Zehner Richard,Baines Anthony J.,Garrett Michelle D.,Gourlay Campbell W.,Griffin Darren K.,Gullick William J.,Hargreaves Emma,Howard Mark J.,Lloyd Daniel R.,Rossman Jeremy S.,Smales C. Mark,Tsaousis Anastasios D.,von der Haar Tobias,Wass Mark N.,Michaelis MartinORCID

Funder

Kent Cancer Trust

Hilfe fuer krebskranke Kinder Frankfurt e.V.

Frankfurter Stiftung fuer krebskranke Kinder

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3